Evernorth Invests $100M for AI Specialty Pharmacy Program
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care.
Evernorth is investing $100 million through 2028 in Pharmacy Forward, an AI-powered program aimed at improving specialty pharmacy operations and patient care.
As lawmakers consider stricter PBM regulation, Cigna launched a “rebate-free” model to give patients upfront drug discounts, but experts question whether it will lead to meaningful change.
March has seen a slew of executive hires, exits and layoffs across the healthcare industry. For example, providers like Providence and Geisinger have appointed new C-suite leaders, and companies like Blue Shield of California and Evernorth have undergone CEO exits. There were also layoffs at organizations including HHS, Blue Cross of Idaho and the University of Pennsylvania Health System.
The annual growth rate of spending for traditional drugs increased from 2.1% in 2021 to 12.8% in 2024, according to Evernorth Research Institute.
While the dawn of a new AI age is certainly exciting, healthcare leaders are still concerned that the industry lacks a comprehensive framework to regulate these new tools. In the absence of these guidelines, healthcare executives are creating their own governance strategies to deploy AI responsibly, executives said during a panel discussion on Thursday at MedCity News’ INVEST Digital Health conference in Dallas.
This year's HLTH conference brought a bevy of news announcements — from partnerships to new product features to acquisitions and more. In this list, MedCity News compiled short summaries for 11 of the conference's most notable announcements.
Immune checkpoint inhibitors are effective cancer treatments, but are expensive. Understanding the least-costly settings for administering treatments, leveraging genomic testing and following evidence-based guidelines can help health plans optimize cancer care, according to Evernorth Research Institute.
Just 10% of women who had post-miscarriage depression during the pandemic received the “full spectrum of treatment” through therapy and antidepressants, according to a new report by Evernorth Research Institute.
An Evernorth study found that in 2021, 25% of adults with ADHD did not receive any treatment, though this is a decrease from 38.5% in 2017. About 21.4% of adults with ADHD received both medication and behavioral therapy in 2021, up from 12.9% in 2017.
About 87% of those with a behavioral health condition also have one or more medical conditions, according to a new analysis from the Evernorth Research Institute.
Express Scripts released several new solutions last week that aim to improve drug price transparency, including a cap on out-of-pocket costs for prescription drugs for consumers. The news comes amid increasing scrutiny against pharmacy benefit managers.
Brightline’s services are now available to all of Evernorth’s employer clients across all 50 states, as well as Cigna’s customers who receive health coverage through their employer or marketplace exchange plans. These services include educational content about mental health concerns, interactive exercises, one-on-one coaching and care with therapists and psychiatrists.
Suicide-related diagnoses in children and adolescents increased 14% since before the pandemic, a new Evernorth analysis shows. Female and Asian/Pacific Islander youth are especially struggling.
The Evernorth report also found that there is a higher prevalence of flu medication prescriptions among children and people living the South. Employers and payers have a responsibility to encourage people to get vaccinated, said Urvashi Patel, vice president of the Evernorth Research Institute.
To combat this issue, Joan Harvey of Evernorth stressed the importance of an omnichannel care model that leverages both in-person and virtual care. She made these comments at the HLTH conference in Las Vegas.